L&G Pharma Breakthrough UCITS ETF
The L&G Pharma Breakthrough UCITS ETF. Ongoing charges are 0,49 % per year, the fund size is EUR 21 m. The distribution yield is 0,9 %.
The FScore rates each company from 0 to 100 on valuation, profitability, stability and dividend.
| # | Top 10 holding | Weight | Sector | FScore |
|---|---|---|---|---|
| 1 | Genmab A/S | 4,0 % | Healthcare | 28,2 |
| 2 | Xeris Pharmaceuticals Inc | 3,1 % | Healthcare | |
| 3 | United Therapeutics Corporation | 2,9 % | Healthcare | |
| 4 | Halozyme Therapeutics Inc | 2,9 % | Healthcare | |
| 5 | AstraZeneca PLC | 2,8 % | Healthcare | |
| 6 | Ligand Pharmaceuticals Incorporated | 2,8 % | Healthcare | |
| 7 | Xencor Inc | 2,8 % | Healthcare | |
| 8 | Biogen Inc | 2,7 % | Healthcare | |
| 9 | Basilea Pharmaceutica AG | 2,7 % | Healthcare | |
| 10 | Eisai Co. Ltd. | 2,6 % | Healthcare |
Composition
Regions
Sectors
Fact sheet
- Official name
- L&G Pharma Breakthrough UCITS ETF
- Issuer
- LGIM Managers (Europe) Limited
- Domicile
- Ireland
- Inception date
- 2018-01-18
- Trading currency
- EUR (XETRA)
- Ongoing charges
- 0,49 % p.a.
- Fund size
- EUR 21 m
Valuation & risk Premium
- P/E (forward)
- P/B
- P/CF
- Volatility 3 Y
- Sharpe ratio 3 Y
- Beta
Planning your retirement portfolio? Find the right second building block.
The planned standard portfolio uses two ETFs from different risk classes. Our presets show suitable equity and bond ETFs.
Frequently asked questions about L&G Pharma Breakthrough UCITS ETF
What are the costs of the L&G Pharma Breakthrough UCITS ETF?
Does the L&G Pharma Breakthrough UCITS ETF pay distributions?
How many holdings does the L&G Pharma Breakthrough UCITS ETF have?
Is the L&G Pharma Breakthrough UCITS ETF suitable for a retirement portfolio?
Look inside every ETF – company by company.
FScore for 2.307 stocks and all ETFs, screener with all metrics, watchlist with FScore alerts and model portfolio.
Data as of 2026-11-18. Returns in EUR; past performance is not an indicator of future results. Automated analysis, not investment advice. No guarantee for accuracy. All index and product names mentioned (e.g. MSCI®, S&P®, STOXX®, FTSE®) are trademarks of their respective owners and are used only to identify the ETF. Finanzoo is not affiliated with the index providers.